Streptococcus agalactiae Causing Neonatal Infections in Portugal (2005-2015): Diversification and Emergence of a CC17/PI-2b Multidrug Resistant Sublineage
- PMID: 28400757
- PMCID: PMC5368217
- DOI: 10.3389/fmicb.2017.00499
Streptococcus agalactiae Causing Neonatal Infections in Portugal (2005-2015): Diversification and Emergence of a CC17/PI-2b Multidrug Resistant Sublineage
Abstract
The molecular characterization of 218 GBS isolates recovered from neonatal invasive infections in Portugal in 2005-2015 revealed the existence of a small number of genetically distinct lineages that were present over a significant time-span. Serotypes III and Ia were dominant in the population, together accounting for >80% of the isolates. Clonal complex 17 included 50% of all isolates, highlighting the importance of the hypervirulent genetic lineage represented by serotype III ST17/rib/PI-1+PI-2b. Serotype Ia was represented mainly by ST23, previously reported as dominant among invasive disease in non-pregnant adults in Portugal, but also by ST24, showing an increased frequency among late-onset disease. Overall erythromycin resistance was 16%, increasing during the study period (p < 0.001). Macrolide resistance was overrepresented among CC1 and CC19 isolates (p < 0.001 and p = 0.008, respectively). While representatives of the hypervirulent CC17 lineage were mostly susceptible to macrolides, we identified for the first time in Europe a recently emerging sublineage characterized by the loss of PI-1 (CC17/PI-2b), simultaneously resistant to macrolides, lincosamides, and tetracycline, also exhibiting high-level resistance to streptomycin and kanamycin. The stability and dominance of CC17 among neonatal invasive infections in the past decades indicates that it is extremely well adapted to its niche; however emerging resistance in this genetic background may have significant implications for the prevention and management of GBS disease.
Keywords: CC17; Streptococcus agalactiae; antimicrobial resistance; invasive disease; neonates.
Figures
Similar articles
-
Genomic insights into the diversity, virulence, and antimicrobial resistance of group B Streptococcus clinical isolates from Saudi Arabia.Front Cell Infect Microbiol. 2024 Apr 22;14:1377993. doi: 10.3389/fcimb.2024.1377993. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38711928 Free PMC article.
-
Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China.Front Microbiol. 2016 Aug 15;7:1265. doi: 10.3389/fmicb.2016.01265. eCollection 2016. Front Microbiol. 2016. PMID: 27574519 Free PMC article.
-
Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.J Med Microbiol. 2018 Nov;67(11):1551-1559. doi: 10.1099/jmm.0.000849. Epub 2018 Sep 28. J Med Microbiol. 2018. PMID: 30265233
-
Group B Streptococcal Neonatal and Early Infancy Infections in Iceland, 1976-2015.Pediatr Infect Dis J. 2019 Jun;38(6):620-624. doi: 10.1097/INF.0000000000002214. Pediatr Infect Dis J. 2019. PMID: 30299423
-
Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.J Clin Microbiol. 2012 Apr;50(4):1219-27. doi: 10.1128/JCM.05488-11. Epub 2012 Jan 4. J Clin Microbiol. 2012. PMID: 22219307 Free PMC article.
Cited by
-
Emergence of Invasive Serotype Ib Sequence Type 10 Group B Streptococcus Disease in Chinese Infants Is Driven by a Tetracycline-Sensitive Clone.Front Cell Infect Microbiol. 2021 May 14;11:642455. doi: 10.3389/fcimb.2021.642455. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34055663 Free PMC article.
-
Genomic characterization of group B Streptococcus from Argentina: insights into prophage diversity, virulence factors and antibiotic resistance genes.Microb Genom. 2025 Apr;11(4):001399. doi: 10.1099/mgen.0.001399. Microb Genom. 2025. PMID: 40266661 Free PMC article.
-
Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007-2019.Emerg Infect Dis. 2020 Nov;26(11):2721-2724. doi: 10.3201/eid2611.201669. Emerg Infect Dis. 2020. PMID: 33079049 Free PMC article.
-
Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study.BMC Microbiol. 2019 Aug 8;19(1):185. doi: 10.1186/s12866-019-1551-2. BMC Microbiol. 2019. PMID: 31395013 Free PMC article.
-
Maternal Carriage in Late-Onset Group B Streptococcus Disease, Italy.Emerg Infect Dis. 2021;27(9):2279-2287. doi: 10.3201/eid2709.210049. Emerg Infect Dis. 2021. PMID: 34423765 Free PMC article.
References
-
- Bekker V., Bijlsma M. W., van de Beek D., Kuijpers T. W., van der Ende A. (2014). Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect. Dis. 14, 1083–1089. 10.1016/S1473-3099(14)70919-3 - DOI - PubMed
-
- Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate - a practical and powerful approch to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289–300.
-
- Campisi E., Rosini R., Ji W., Guidotti S., Rojas-López M., Geng G., et al. . (2016). Genomic analysis reveals multi-drug resistance clusters in Group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in Southern Mainland China. Front. Microbiol. 7:1265. 10.3389/fmicb.2016.01265 - DOI - PMC - PubMed
-
- Carrico J. A., Silva-Costa C., Melo-Cristino J., Pinto F. R., de Lencastre H., Almeida J. S., et al. . (2006). Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J. Clin. Microbiol. 44, 2524–2532. 10.1128/JCM.02536-05 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous